ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
22K |
51 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
22K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
22K |
38 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
22K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
22K |
15 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
22K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
22K |
65 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
22K
|
65
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Mason14
|
132 |
31K |
23 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
132
|
31K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
22K |
31 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
81
|
22K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Mason14
|
81 |
22K |
60 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
81
|
22K
|
60
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.2K |
737K |
31 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
2.2K
|
737K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.2K |
737K |
35 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
2.2K
|
737K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.2K |
737K |
14 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
2.2K
|
737K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
2.9K |
1.0M |
33 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Mason14
|
2.2K |
737K |
11 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
2.2K
|
737K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
216 |
62K |
24 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
216
|
62K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
216 |
62K |
38 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
216
|
62K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
216 |
62K |
105 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
216
|
62K
|
105
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
28 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
905
|
269K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
21 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
905
|
269K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
13 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
13 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
21 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
13 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
23 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
40 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
7 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
24 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
9 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
33 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
8 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
16 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
61 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
905
|
269K
|
61
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
7 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
905
|
269K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
22K |
7.7M |
2 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
22K
|
7.7M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
58 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
905
|
269K
|
58
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
28 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
905
|
269K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
55 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
905
|
269K
|
55
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
905 |
269K |
50 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
905
|
269K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
13 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
44K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
24 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
44K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
36 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
44K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
62 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
44K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
73 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
44K
|
73
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
44 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
146
|
44K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
18 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
44K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
45 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
44K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
Mason14
|
38 |
8.0K |
6 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
8.0K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
Mason14
|
38 |
8.0K |
43 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
8.0K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
50 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
44K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
50 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
146
|
44K
|
50
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
216 |
62K |
55 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
216
|
62K
|
55
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
Mason14
|
146 |
44K |
76 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
146
|
44K
|
76
|
|